Fusion peptides and the mechanism of viral fusion

Biochimica et Biophysica Acta - Biomembranes

Volumn 1614, Issue 1, 2003, Pages 116-121

  Epand, Richard M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Fusion peptide; Peptide membrane interaction; Viral fusion

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ; VIRUS FUSION PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLUENZA VIRUS; LIPID MONOLAYER; MEMBRANE FUSION; MEMBRANE RUPTURE; MOLECULAR DYNAMICS; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; STRUCTURE ANALYSIS; VIRUS ADSORPTION; VIRUS ENVELOPE;

EID: 0038487375     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(03)00169-X     Document Type: Review

References (48)

1. Qiao H., Armstrong R.T., Melikyan G.B., Cohen F.S., White J.M. A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype. Mol. Biol. Cell. 10:1999;2759-2769.
2. Wimley W.C., White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3:1996;842-848.
3. Luneberg J., Martin I., Nussler F., Ruysschaert J.M., Herrmann A. Structure and topology of the influenza virus fusion peptide in lipid bilayers. J. Biol. Chem. 270:1995;27606-27614.
4. Horth M., Lambrecht B., Khim M.C., Bex F., Thiriart C., Ruysschaert J.M., Burny A., Brasseur R. Theoretical and functional analysis of the SIV fusion peptide. EMBO J. 10:1991;2747-2755.
5. Martin I., Dubois M.C., Defrise-Quertain F., Saermark T., Burny A., Brasseur R., Ruysschaert J.M. Correlation between fusogenicity of synthetic modified peptides corresponding to the NH2-terminal extremity of simian immunodeficiency virus gp32 and their mode of insertion into the lipid bilayer: an infrared spectroscopy study. J. Virol. 68:1994;1139-1148.
6. Bradshaw J.P., Darkes M.J., Harroun T.A., Katsaras J., Epand R.M. Oblique membrane insertion of viral fusion peptide probed by neutron diffraction. Biochemistry. 39:2000;6581-6585.
7. Han X., Bushweller J.H., Cafiso D.S., Tamm L.K. Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin. Nat. Struct. Biol. 8:2001;715-720.
8. Hsu C.H., Wu S.H., Chang D.K., Chen C. Structural characterizations of fusion peptide analogs of influenza virus hemagglutinin. Implication of the necessity of a helix-hinge-helix motif in fusion activity. J. Biol. Chem. 277:2002;22725-22733.
9. Yang J., Gabrys C.M., Weliky D.P. Solid-state nuclear magnetic resonance evidence for an extended beta strand conformation of the membrane-bound HIV-1 fusion peptide. Biochemistry. 40:2001;8126-8137.
10. Peisajovich S.G., Epand R.F., Pritsker M., Shai Y., Epand R.M. The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry. 39:2000;1826-1833.
11. Delos S.E., Gilbert J.M., White J.M. The central proline of an internal viral fusion peptide serves two important roles. J. Virol. 74:2000;1686-1693.
12. Delos S.E., White J.M. Critical role for the cysteines flanking the internal fusion peptide of avian sarcoma/leukosis virus envelope glycoprotein. J. Virol. 74:2000;9738-9741.
13. Hernandez L.D., White J.M. Mutational analysis of the candidate internal fusion peptide of the avian leukosis and sarcoma virus subgroup A envelope glycoprotein. J. Virol. 72:1998;3259-3267.
14. Shokralla S., Chernish R., Ghosh H.P. Effects of double-site mutations of vesicular stomatitis virus glycoprotein G on membrane fusion activity. Virology. 256:1999;119-129.
15. Shmulevitz M., Duncan R. A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses. EMBO J. 19:2000;902-912.
16. Epand R.M. Lipid polymorphism and protein-lipid interactions. Biochim. Biophys. Acta. 1376:1998;353-368.
17. Epand R.M., Epand R.F. Relationship between the infectivity of influenza virus and the ability of its fusion peptide to perturb bilayers. Biochem. Biophys. Res. Commun. 202:1994;1420-1425.
18. Epand R.M., Epand R.F., Martin I., Ruysschaert J.M. Membrane interactions of mutated forms of the influenza fusion peptide. Biochemistry. 40:2001;8800-8807.
19. Colotto A., Martin I., Ruysschaert J.M., Sen A., Hui S.W., Epand R.M. Structural study of the interaction between the SIV fusion peptide and model membranes. Biochemistry. 35:1996;980-989.
20. Epand R.F., Martin I., Ruysschaert J.M., Epand R.M. Membrane orientation of the SIV fusion peptide determines its effect on bilayer stability and ability to promote membrane fusion. Biochem. Biophys. Res. Commun. 205:1994;1938-1943.
21. Siegel D.P. The modified stalk mechanism of lamellar/inverted phase transitions and its implications for membrane fusion. Biophys. J. 76:1999;291-313.
22. Chernomordik L. Non-bilayer lipids and biological fusion intermediates. Chem. Phys. Lipids. 81:1996;203-213.
23. Durrer P., Galli C., Hoenke S., Corti C., Gluck R., Vorherr T., Brunner J. H+-induced membrane insertion of influenza virus hemagglutinin involves the HA2 amino-terminal fusion peptide but not the coiled coil region. J. Biol. Chem. 271:1996;13417-13421.
24. Kozlov M.M., Chernomordik L.V. A mechanism of protein-mediated fusion: coupling between refolding of the influenza hemagglutinin and lipid rearrangements. Biophys. J. 75:1998;1384-1396.
25. Evans E., Needham D. Physical properties of surfactant bilayer membranes: thermal transitions, elasticity, rigidity, cohesion and colloidal interactions. J. Phys. Chem. 91:1987;4219-4228.
26. Longo M.L., Waring A.J., Hammer D.A. Interaction of the influenza hemagglutinin fusion peptide with lipid bilayers: area expansion and permeation. Biophys. J. 73:1997;1430-1439.
27. Siegel D.P., Epand R.M. Effect of influenza hemagglutinin fusion peptide on lamellar/inverted phase transition in dipalmitoleoylphosphatidylethanolamine: implications for membrane fusion mechanisms. Biochim. Biophys. Acta. 1468:2000;87-98.
28. Markovic I., Leikina E., Zhukovsky M., Zimmerberg J., Chernomordik L.V. Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines. J. Cell Biol. 155:2001;833-844.
29. Hernandez L.D., Hoffman L.R., Wolfsberg T.G., White J.M. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:1996;627-661.
30. Schroth-Diez B., Ludwig K., Baljinnyam B., Kozerski C., Huang Q., Herrmann A. The role of the transmembrane and of the intraviral domain of glycoproteins in membrane fusion of enveloped viruses. Biosci. Rep. 20:2000;571-595.
31. Lear J.D., DeGrado W.F. Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J. Biol. Chem. 262:1987;6500-6505.
32. Haque M.E., McCoy A.J., Glenn J., Lee J., Lentz B.R. Effects of hemagglutinin fusion peptide on poly(ethylene glycol)-mediated fusion of phosphatidylcholine vesicles. Biochemistry. 40:2001;14243-14251.
33. Leikina E., LeDuc D.L., Macosko J.C., Epand R., Epand R., Shin Y.K., Chernomordik L.V. The 1-127 HA2 construct of influenza virus hemagglutinin induces cell-cell hemifusion. Biochemistry. 40:2001;8378-8386.
34. Shangguan T., Alford D., Bentz J. Influenza-virus-liposome lipid mixing is leaky and largely insensitive to the material properties of the target membrane. Biochemistry. 35:1996;4956-4965.
35. Epand R.F., Macosko J.C., Russell C.J., Shin Y.K., Epand R.M. The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion. J. Mol. Biol. 286:1999;489-503.
36. Peisajovich S.G., Shai Y. New insights into the mechanism of virus-induced membrane fusion. Trends Biochem. Sci. 27:2002;183-190.
37. Peisajovich S.G., Samuel O., Shai Y. Paramyxovirus F1 protein has two fusion peptides: implications for the mechanism of membrane fusion. J. Mol. Biol. 296:2000;1353-1365.
38. Ghosh J.K., Peisajovich S.G., Shai Y. Sendai virus internal fusion peptide: structural and functional characterization and a plausible mode of viral entry inhibition. Biochemistry. 39:2000;11581-11592.
39. Samuel O., Shai Y. Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses. Biochemistry. 40:2001;1340-1349.
40. Rabenstein M., Shin Y.K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry. 34:1995;13390-13397.
41. Nieva J.L., Suarez T. Hydrophobic-at-interface regions in viral fusion protein ectodomains. Biosci. Rep. 20:2000;519-533.
42. Suarez T., Gallaher W.R., Agirre A., Goni F.M., Nieva J.L. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J. Virol. 74:2000;8038-8047.
43. Epand R.M., Epand R.F. The thermal denaturation of influenza virus and its relationship to membrane fusion. Biochem. J. 365:2002;841-848.
44. Epand R.F., Epand R.M. Irreversible unfolding of the neutral pH form influenza hemagglutinin demonstrates it is not in a metastable state. Biochemistry. 42:2003;5052-5057.
45. Bullough P.A., Hughson F.M., Skehel J.J., Wiley D.C. Structure of influenza haemagglutinin at the pH of membrane fusion [see comments]. Nature. 371:1994;37-43.
46. Huang Q., Opitz R., Knapp E.W., Herrmann A. Protonation and stability of the globular domain of influenza virus hemagglutinin. Biophys. J. 82:2002;1050-1058.
47. Wilson I.A., Skehel J.J., Wiley D.C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature. 289:1981;366-373.
48. Korte T., Epand R.F., Epand R.M., Blumenthal R. Role of the Glu residues of the influenza hemagglutinin fusion peptide in the pH dependence of fusion activity. Virology. 289:2001;353-361.